Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. (Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016)